Home/Filings/4/A/0001235802-04-000094
4/A//SEC Filing

BIOSANTE PHARMACEUTICALS INC 4/A

Accession 0001235802-04-000094

$ANIPCIK 0001023024operating

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 12:51 PM ET

Size

8.1 KB

Accession

0001235802-04-000094

Insider Transaction Report

Form 4/AAmended
Period: 2004-03-18
Transactions
  • Award

    Common Stock

    2004-03-18+211396,332 total
Holdings
  • Common Stock

    (indirect: By Trust)
    283,281
  • Common Stock

    (indirect: By Spouse)
    70,000
  • Common Stock

    (indirect: By Resolute Partners)
    63,281
Footnotes (4)
  • [F1]Mr. Morgenstern acquired these shares as a stock award for director compensation granted under BioSante Pharmaceutical's Amended and Restated 1998 Stock Plan.
  • [F2]Not applicable.
  • [F3]Held by Morningstar Trust to which Mr. Morgenstern's wife is a trustee. Mr. Morgenstern disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F4]Held by Resolute Partners to which Mr. Morgenstern is a managing director.

Issuer

BIOSANTE PHARMACEUTICALS INC

CIK 0001023024

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001023024

Filing Metadata

Form type
4/A
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 12:51 PM ET
Size
8.1 KB